Debbie Parker

5.9k total citations · 2 hit papers
25 papers, 4.2k citations indexed

About

Debbie Parker is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Emergency Medical Services. According to data from OpenAlex, Debbie Parker has authored 25 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 19 papers in Physiology and 6 papers in Emergency Medical Services. Recurrent topics in Debbie Parker's work include Asthma and respiratory diseases (19 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers) and Respiratory and Cough-Related Research (9 papers). Debbie Parker is often cited by papers focused on Asthma and respiratory diseases (19 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers) and Respiratory and Cough-Related Research (9 papers). Debbie Parker collaborates with scholars based in United Kingdom, United States and Denmark. Debbie Parker's co-authors include Ian Pavord, Christopher E. Brightling, Andrew J. Wardlaw, Peter Bradding, Beverley Hargadon, Ruth H. Green, Susan McKenna, Dominick Shaw, William Monteiro and M. Shelley and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Debbie Parker

25 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial

2002 1.3k citations Ruth H. Green, Christopher E. Brightling et al. The Lancet profile →
Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma

2006 631 citations Beverley Hargadon, M. Shelley et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Debbie Parker United Kingdom	19	3.6k	3.1k	721	470	426	25	4.2k
Anneke Ten Brinke Netherlands	27	4.3k 1.2×	3.0k 1.0×	940 1.3×	372 0.8×	1.1k 2.5×	73	4.9k
Viktoría Werkström Sweden	17	2.1k 0.6×	1.4k 0.5×	505 0.7×	207 0.4×	615 1.4×	32	2.9k
Antonio Foresi Italy	29	2.5k 0.7×	2.2k 0.7×	350 0.5×	165 0.4×	785 1.8×	79	3.3k
Krishnan Parameswaran Canada	23	1.6k 0.5×	1.3k 0.4×	286 0.4×	132 0.3×	406 1.0×	33	2.2k
Adel Mansur United Kingdom	25	2.0k 0.6×	1.6k 0.5×	312 0.4×	117 0.2×	358 0.8×	88	2.4k
T Kava Finland	16	2.5k 0.7×	2.0k 0.7×	192 0.3×	175 0.4×	389 0.9×	20	3.0k
H. J. Sluiter Netherlands	27	2.2k 0.6×	2.1k 0.7×	261 0.4×	155 0.3×	601 1.4×	67	3.5k
LP Boulet Canada	28	2.7k 0.8×	2.2k 0.7×	237 0.3×	177 0.4×	981 2.3×	54	3.2k
Donald Payne United Kingdom	22	2.1k 0.6×	2.0k 0.6×	244 0.3×	269 0.6×	238 0.6×	61	2.8k
Emanuele Crimi Italy	29	2.0k 0.5×	1.6k 0.5×	382 0.5×	109 0.2×	693 1.6×	98	2.6k

Countries citing papers authored by Debbie Parker

Since Specialization

Citations

This map shows the geographic impact of Debbie Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debbie Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debbie Parker more than expected).

Fields of papers citing papers by Debbie Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debbie Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debbie Parker. The network helps show where Debbie Parker may publish in the future.

Co-authorship network of co-authors of Debbie Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Debbie Parker. A scholar is included among the top collaborators of Debbie Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debbie Parker. Debbie Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meteran, Howraman, Morten Hostrup, Nina Rica Wium Geiker, et al.. (2017). Effects of Exercise and Diet in Nonobese Asthma Patients—A Randomized Controlled Trial. The Journal of Allergy and Clinical Immunology In Practice. 6(3). 803–811. 63 indexed citations

Meteran, Howraman, Morten Hostrup, Celeste Porsbjerg, et al.. (2017). Exercise and diet improve asthma controlin non-obese asthma patients - a randomised controlled trial. OA4678–OA4678. 1 indexed citations

Barnes, N., Ian Pavord, А. Г. Чучалин, et al.. (2011). A randomized, double‐blind, placebo‐controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma. Clinical & Experimental Allergy. 42(1). 38–48. 175 indexed citations

Yousaf, Nadia, William Monteiro, Debbie Parker, et al.. (2010). Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial. Thorax. 65(12). 1107–1110. 45 indexed citations

Pavord, Ian, Peter K. Jeffery, Yusheng Qiu, et al.. (2009). Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. Journal of Allergy and Clinical Immunology. 123(5). 1083–1089.e7. 50 indexed citations

Doe, Camille, Vijay Mistry, Salman Siddiqui, et al.. (2009). Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD. Thorax. 64(8). 671–676. 80 indexed citations

Mistry, Vijay, Roshan Siva, Debbie Parker, et al.. (2008). Induced sputum and bronchial mucosal expression of interleukin‐13 is not increased in chronic obstructive pulmonary disease. Allergy. 63(9). 1239–1243. 16 indexed citations

Siva, Roshan, Christopher E. Brightling, M. Shelley, et al.. (2007). Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. European Respiratory Journal. 29(5). 906–913. 343 indexed citations

Berry, M A, Angela Morgan, Dominick Shaw, et al.. (2007). Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax. 62(12). 1043–1049. 330 indexed citations

10.

Barnes, Neil, Michel Laviolette, David J. Allen, et al.. (2007). Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control. Respiratory Medicine. 101(8). 1652–1658. 16 indexed citations

11.

Pavord, Ian, et al.. (2007). Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma. Respiratory Research. 8(1). 10 indexed citations

12.

Brightling, Christopher E., Sharon L. McKenna, B. Hargadon, et al.. (2006). Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness. European Respiratory Journal. 27(6). 1144–1151. 55 indexed citations

13.

Barnes, Neil, Yusheng Qiu, Ian Pavord, et al.. (2006). Antiinflammatory Effects of Salmeterol/Fluticasone Propionate in Chronic Obstructive Lung Disease. American Journal of Respiratory and Critical Care Medicine. 173(7). 736–743. 205 indexed citations

14.

Birring, Surinder S., Debbie Parker, Susan McKenna, et al.. (2005). Sputum eosinophilia in idiopathic pulmonary fibrosis. Inflammation Research. 54(2). 51–56. 28 indexed citations

15.

Birring, Surinder S., Debbie Parker, Christopher E. Brightling, et al.. (2003). Induced Sputum Inflammatory Mediator Concentrations in Chronic Cough. American Journal of Respiratory and Critical Care Medicine. 169(1). 15–19. 148 indexed citations

16.

Birring, SS, Debbie Parker, Susan McKenna, et al.. (2003). Induced sputum mediator concentrations in COPD. Thorax. 58. 87–87. 1 indexed citations

17.

Brightling, Christopher E., Susan McKenna, Beverley Hargadon, et al.. (2002). A placebo controlled comparison of formoterol, montelukast or higher dose of inhaled corticosteroids in subjects with symptomatic asthma despite treatment with low dose inhaled corticosteroids. Thorax. 57. 9 indexed citations

18.

Green, Ruth H., Christopher E. Brightling, Susan McKenna, et al.. (2002). Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. The Lancet. 360(9347). 1715–1721. 1283 indexed citations breakdown →

19.

Brightling, Christopher E., et al.. (2001). Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respiratory Medicine. 95(12). 999–1002. 83 indexed citations

20.

Brightling, Christopher E., William Monteiro, Richard J. Ward, et al.. (2000). Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. The Lancet. 356(9240). 1480–1485. 419 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact